ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Gross of the placeholder expense ratio and trading costs · not investor results
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1NVDA | NVIDIA CORP | Technology | $4.01T | 25.09% |
2TSLA | TESLA INC | Consumer Cyclical | $1.57T | 9.84% |
3LLY | ELI LILLY & CO | Healthcare | $1.34T | 8.41% |
4MU | MICRON TECHNOLOGY INC | Technology | $903.37B | 5.66% |
5V | VISA INC | Financial Services | $783.16B | 4.91% |
6JNJ | JOHNSON & JOHNSON | Healthcare | $682.52B | 4.28% |
7MA | MASTERCARD INC | Financial Services | $568.53B | 3.56% |
8MRK | MERCK & CO INC | Healthcare | $362.27B | 2.27% |
9HD | HOME DEPOT INC | Consumer Cyclical | $347.46B | 2.18% |
10AMGN | AMGEN INC | Healthcare | $252.64B | 1.58% |
11VZ | VERIZON COMMUNICATIONS INC | Communication Services | $192.93B | 1.21% |
12ABT | ABBOTT LABORATORIES | Healthcare | $185.75B | 1.16% |
13TMUS | T-MOBILE US INC | Communication Services | $181.17B | 1.13% |
14PFE | PFIZER INC | Healthcare | $164.33B | 1.03% |
15ISRG | INTUITIVE SURGICAL INC | Healthcare | $152.49B | 0.96% |
16T | AT&T INC | Communication Services | $149.41B | 0.94% |
17LMT | LOCKHEED MARTIN CORP | Industrials | $139.55B | 0.87% |
18VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | $137.57B | 0.86% |
19BA | BOEING CO | Industrials | $135.94B | 0.85% |
20APP | APPLOVIN CORP | Technology | $130.43B | 0.82% |
21BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $127.39B | 0.80% |
22STX | SEAGATE TECHNOLOGY HOLDINGS PLC | Technology | $125.14B | 0.78% |
23ADP | AUTOMATIC DATA PROCESSING INC | Industrials | $121.55B | 0.76% |
24MPC | MARATHON PETROLEUM CORP | Energy | $112.41B | 0.70% |
25REGN | REGENERON PHARMACEUTICALS INC | Healthcare | $98.40B | 0.62% |
26MMM | 3M CO | Industrials | $96.24B | 0.60% |
27FTNT | FORTINET INC | Technology | $95.17B | 0.60% |
28ADBE | ADOBE INC | Technology | $92.84B | 0.58% |
29MNST | MONSTER BEVERAGE CORP | Consumer Defensive | $89.20B | 0.56% |
30BX | BLACKSTONE INC | Financial Services | $89.04B | 0.56% |
31CMCSA | COMCAST CORP | Communication Services | $88.06B | 0.55% |
32AMT | AMERICAN TOWER CORP | Real Estate | $88.02B | 0.55% |
33MSI | MOTOROLA SOLUTIONS INC | Technology | $87.69B | 0.55% |
34MCO | MOODYS CORP | Financial Services | $87.33B | 0.55% |
35SHW | SHERWIN WILLIAMS CO | Basic Materials | $84.89B | 0.53% |
36ITW | ILLINOIS TOOL WORKS INC | Industrials | $81.49B | 0.51% |
37SPG | SIMON PROPERTY GROUP INC | Real Estate | $75.33B | 0.47% |
38GM | GENERAL MOTORS CO | Consumer Cyclical | $72.76B | 0.46% |
39COR | CENCORA INC | Healthcare | $66.67B | 0.42% |
40PCAR | PACCAR INC | Industrials | $55.98B | 0.35% |
41IDXX | IDEXX LABORATORIES INC | Healthcare | $54.99B | 0.34% |
42TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | $50.93B | 0.32% |
43ONC | BEONE MEDICINES LTD | Healthcare | $47.50B | 0.30% |
44AMP | AMERIPRISE FINANCIAL INC | Financial Services | $44.58B | 0.28% |
45UI | UBIQUITI INC | Technology | $41.32B | 0.26% |
46RPRX | ROYALTY PHARMA PLC | Healthcare | $39.56B | 0.25% |
47SKYD | SKYDANCE CORP | Communication Services | $38.29B | 0.24% |
48BIIB | BIOGEN INC | Healthcare | $37.03B | 0.23% |
49GEHC | GE HEALTHCARE TECHNOLOGIES INC | Healthcare | $37.00B | 0.23% |
50KMB | KIMBERLY CLARK CORP | Consumer Defensive | $35.65B | 0.22% |
51MTD | METTLER TOLEDO INTERNATIONAL INC | Healthcare | $34.43B | 0.22% |
52ZTS | ZOETIS INC | Healthcare | $33.71B | 0.21% |
53RMD | RESMED INC | Healthcare | $33.60B | 0.21% |
54EXPE | EXPEDIA GROUP INC | Consumer Cyclical | $30.95B | 0.19% |
55DXCM | DEXCOM INC | Healthcare | $30.35B | 0.19% |
56CQP | CHENIERE ENERGY PARTNERS LP | Energy | $29.72B | 0.19% |
57ECHO | ECHOSTAR CORP | Communication Services | $28.55B | 0.18% |
58FOXA | FOX CORP | Communication Services | $27.72B | 0.17% |
59JBL | JABIL INC | Technology | $26.77B | 0.17% |
60FWONA | LIBERTY MEDIA CORP | Communication Services | $26.21B | 0.16% |
61TPR | TAPESTRY INC | Consumer Cyclical | $26.06B | 0.16% |
62UTHR | UNITED THERAPEUTICS CORP | Healthcare | $25.27B | 0.16% |
63LVS | LAS VEGAS SANDS CORP | Consumer Cyclical | $24.66B | 0.15% |
64ROKU | ROKU INC | Communication Services | $23.93B | 0.15% |
65SW | SMURFIT WESTROCK PLC | Consumer Cyclical | $22.65B | 0.14% |
66PKG | PACKAGING CORP OF AMERICA | Consumer Cyclical | $22.33B | 0.14% |
67ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $20.98B | 0.13% |
68GH | GUARDANT HEALTH INC | Healthcare | $20.95B | 0.13% |
69TPL | TEXAS PACIFIC LAND CORP | Energy | $19.39B | 0.12% |
70FTAI | FTAI AVIATION LTD | Industrials | $18.70B | 0.12% |
71MEDP | MEDPACE HOLDINGS INC | Healthcare | $18.37B | 0.12% |
72NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.15B | 0.11% |
73BALL | BALL CORP | Consumer Cyclical | $16.90B | 0.11% |
74LAMR | LAMAR ADVERTISING CO | Real Estate | $16.22B | 0.10% |
75JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | $15.43B | 0.10% |
76BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.23B | 0.10% |
77CHTR | CHARTER COMMUNICATIONS INC | Communication Services | $15.18B | 0.10% |
78MANH | MANHATTAN ASSOCIATES INC | Technology | $14.89B | 0.09% |
79GDDY | GODADDY INC | Technology | $13.62B | 0.09% |
80CCK | CROWN HOLDINGS INC | Consumer Cyclical | $13.02B | 0.08% |
81IT | GARTNER INC | Technology | $12.04B | 0.08% |
82HALO | HALOZYME THERAPEUTICS INC | Healthcare | $11.48B | 0.07% |
83TECH | BIO-TECHNE CORP | Healthcare | $11.44B | 0.07% |
84EVR | EVERCORE INC | Financial Services | $11.22B | 0.07% |
85BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $10.98B | 0.07% |
86SIRI | SIRIUS XM HOLDINGS INC | Communication Services | $10.68B | 0.07% |
87RGEN | REPLIGEN CORP | Healthcare | $10.64B | 0.07% |
88PODD | INSULET CORP | Healthcare | $10.36B | 0.06% |
89ALSN | ALLISON TRANSMISSION HOLDINGS INC | Consumer Cyclical | $10.32B | 0.06% |
90BAH | BOOZ ALLEN HAMILTON HOLDING CORP | Industrials | $10.25B | 0.06% |
91BWA | BORGWARNER INC | Consumer Cyclical | $10.24B | 0.06% |
92HNGE | HINGE HEALTH INC | Healthcare | $9.83B | 0.06% |
93TGTX | TG THERAPEUTICS INC | Healthcare | $9.76B | 0.06% |
94MUSA | MURPHY USA INC | Consumer Cyclical | $9.68B | 0.06% |
95VIRT | VIRTU FINANCIAL INC | Financial Services | $9.26B | 0.06% |
96MORN | MORNINGSTAR INC | Financial Services | $9.13B | 0.06% |
97KRYS | KRYSTAL BIOTECH INC | Healthcare | $9.06B | 0.06% |
98PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $8.77B | 0.05% |
99PRMB | PRIMO BRANDS CORP | Consumer Defensive | $8.61B | 0.05% |
100OSK | OSHKOSH CORP | Industrials | $8.56B | 0.05% |
101ALV | AUTOLIV INC | Consumer Cyclical | $8.56B | 0.05% |
102EAT | BRINKER INTERNATIONAL INC | Consumer Cyclical | $8.21B | 0.05% |
103CORT | CORCEPT THERAPEUTICS INC | Healthcare | $8.07B | 0.05% |
104CELH | CELSIUS HOLDINGS INC | Consumer Defensive | $7.99B | 0.05% |
105ALKS | ALKERMES PLC | Healthcare | $7.89B | 0.05% |
106CYTK | CYTOKINETICS INC | Healthcare | $7.82B | 0.05% |
107KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $7.56B | 0.05% |
108AMRX | AMNEAL PHARMACEUTICALS INC | Healthcare | $7.56B | 0.05% |
109YOU | CLEAR SECURE INC | Technology | $7.46B | 0.05% |
110ORKA | ORUKA THERAPEUTICS INC | Healthcare | $7.12B | 0.04% |
111FSS | FEDERAL SIGNAL CORP | Industrials | $7.02B | 0.04% |
112CVLT | COMMVAULT SYSTEMS INC | Technology | $6.80B | 0.04% |
113MSA | MSA SAFETY INC | Industrials | $6.73B | 0.04% |
114LNTH | LANTHEUS HOLDINGS INC | Healthcare | $6.62B | 0.04% |
115TEX | TEREX CORP | Industrials | $6.47B | 0.04% |
116IBRX | IMMUNITYBIO INC | Healthcare | $6.46B | 0.04% |
117FTDR | FRONTDOOR INC | Consumer Cyclical | $6.45B | 0.04% |
118NXST | NEXSTAR MEDIA GROUP INC | Communication Services | $6.35B | 0.04% |
119LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.33B | 0.04% |
120LYFT | LYFT INC | Technology | $6.28B | 0.04% |
121OUT | OUTFRONT MEDIA INC | Real Estate | $5.85B | 0.04% |
122STEP | STEPSTONE GROUP INC | Financial Services | $5.74B | 0.04% |
123MOD | MODINE MANUFACTURING CO | Consumer Cyclical | $5.64B | 0.04% |
124PTCT | PTC THERAPEUTICS INC | Healthcare | $5.29B | 0.03% |
125CHH | CHOICE HOTELS INTERNATIONAL INC | Consumer Cyclical | $5.26B | 0.03% |
126LEA | LEAR CORP | Consumer Cyclical | $5.23B | 0.03% |
127SEZL | SEZZLE INC | Financial Services | $5.23B | 0.03% |
128EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | $5.02B | 0.03% |
129VSNT | VERSANT MEDIA GROUP INC | Communication Services | $4.86B | 0.03% |
130GFF | GRIFFON CORP | Industrials | $4.75B | 0.03% |
131FHI | FEDERATED HERMES INC | Financial Services | $4.70B | 0.03% |
132ATMU | ATMUS FILTRATION TECHNOLOGIES INC | Industrials | $4.53B | 0.03% |
133MC | MOELIS & CO | Financial Services | $4.37B | 0.03% |
134MTRN | MATERION CORP | Basic Materials | $4.34B | 0.03% |
135SLGN | SILGAN HOLDINGS INC | Consumer Cyclical | $4.30B | 0.03% |
136DK | DELEK US HOLDINGS INC | Energy | $4.15B | 0.03% |
137THO | THOR INDUSTRIES INC | Consumer Cyclical | $3.99B | 0.02% |
138GNTX | GENTEX CORP | Consumer Cyclical | $3.98B | 0.02% |
139NVST | ENVISTA HOLDINGS CORP | Healthcare | $3.95B | 0.02% |
140DORM | DORMAN PRODUCTS INC | Consumer Cyclical | $3.89B | 0.02% |
141PJT | PJT PARTNERS INC | Financial Services | $3.82B | 0.02% |
142MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.74B | 0.02% |
143OGN | ORGANON & CO | Healthcare | $3.65B | 0.02% |
144ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.48B | 0.02% |
145DAVE | DAVE INC | Technology | $3.42B | 0.02% |
146FIZZ | NATIONAL BEVERAGE CORP | Consumer Defensive | $3.39B | 0.02% |
147AAMI | ACADIAN ASSET MANAGEMENT INC | Financial Services | $3.36B | 0.02% |
148TDS | TELEPHONE & DATA SYSTEMS INC | Communication Services | $3.36B | 0.02% |
149TMDX | TRANSMEDICS GROUP INC | Healthcare | $3.20B | 0.02% |
150GPK | GRAPHIC PACKAGING HOLDING CO | Consumer Cyclical | $3.19B | 0.02% |
151NHI | NATIONAL HEALTH INVESTORS INC | Real Estate | $3.17B | 0.02% |
152ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $3.14B | 0.02% |
153TDC | TERADATA CORP | Technology | $3.12B | 0.02% |
154DKL | DELEK LOGISTICS PARTNERS LP | Energy | $3.10B | 0.02% |
155APAM | ARTISAN PARTNERS ASSET MANAGEMENT INC | Financial Services | $3.09B | 0.02% |
156BHC | BAUSCH HEALTH COMPANIES INC | Healthcare | $3.09B | 0.02% |
157CARG | CARGURUS INC | Consumer Cyclical | $3.06B | 0.02% |
158TNET | TRINET GROUP INC | Industrials | $2.99B | 0.02% |
159ADMA | ADMA BIOLOGICS INC | Healthcare | $2.94B | 0.02% |
160VCEL | VERICEL CORP | Healthcare | $2.93B | 0.02% |
161GCMG | GCM GROSVENOR INC | Financial Services | $2.75B | 0.02% |
162CXW | CORECIVIC INC | Industrials | $2.72B | 0.02% |
163PHIN | PHINIA INC | Consumer Cyclical | $2.61B | 0.02% |
164ATRO | ASTRONICS CORP | Industrials | $2.59B | 0.02% |
165GRND | GRINDR INC | Technology | $2.55B | 0.02% |
166LTC | LTC PROPERTIES INC | Real Estate | $2.46B | 0.02% |
167RH | RH | Consumer Cyclical | $2.45B | 0.02% |
168BLKB | BLACKBAUD INC | Technology | $2.41B | 0.02% |
169AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $2.36B | 0.01% |
170LCII | LCI INDUSTRIES | Consumer Cyclical | $2.36B | 0.01% |
171DAN | DANA INC | Consumer Cyclical | $2.27B | 0.01% |
172AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | $2.17B | 0.01% |
173PBH | PRESTIGE CONSUMER HEALTHCARE INC | Healthcare | $2.15B | 0.01% |
174CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $2.11B | 0.01% |
175NGVT | INGEVITY CORP | Basic Materials | $2.09B | 0.01% |
176IDT | IDT CORP | Communication Services | $2.06B | 0.01% |
177CALX | CALIX INC | Technology | $2.02B | 0.01% |
178HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.98B | 0.01% |
179BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $1.98B | 0.01% |
180VC | VISTEON CORP | Consumer Cyclical | $1.95B | 0.01% |
181NGL | NGL ENERGY PARTNERS LP | Energy | $1.95B | 0.01% |
182ADEA | ADEIA INC | Technology | $1.84B | 0.01% |
183ZYME | ZYMEWORKS INC | Healthcare | $1.83B | 0.01% |
184ETON | ETON PHARMACEUTICALS INC | Healthcare | $1.77B | 0.01% |
185BLBD | BLUE BIRD CORP | Consumer Cyclical | $1.76B | 0.01% |
186SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.72B | 0.01% |
187ZD | ZIFF DAVIS INC | Communication Services | $1.71B | 0.01% |
188NRIX | NURIX THERAPEUTICS INC | Healthcare | $1.70B | 0.01% |
189CBL | CBL & ASSOCIATES PROPERTIES INC | Real Estate | $1.68B | 0.01% |
190RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $1.66B | 0.01% |
191ATEX | ANTERIX INC | Communication Services | $1.63B | 0.01% |
192ANIP | ANI PHARMACEUTICALS INC | Healthcare | $1.62B | 0.01% |
193WEN | WENDY'S CO | Consumer Cyclical | $1.56B | 0.01% |
194THRM | GENTHERM INC | Consumer Cyclical | $1.51B | 0.01% |
195PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.46B | 0.01% |
196NVAX | NOVAVAX INC | Healthcare | $1.45B | 0.01% |
197PAHC | PHIBRO ANIMAL HEALTH CORP | Healthcare | $1.44B | 0.01% |
198ANAB | ANAPTYSBIO INC | Healthcare | $1.43B | 0.01% |
199PBT | PERMIAN BASIN ROYALTY TRUST | Energy | $1.41B | 0.01% |
200TRS | TRIMAS CORP | Consumer Cyclical | $1.35B | 0.01% |
201INVA | INNOVIVA INC | Healthcare | $1.35B | 0.01% |
202SECZ | SECURITIZE CORP | Technology | $1.30B | 0.01% |
203URGN | UROGEN PHARMA LTD | Healthcare | $1.29B | 0.01% |
204INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.29B | 0.01% |
205ALX | ALEXANDERS INC | Real Estate | $1.26B | 0.01% |
206PD | PAGERDUTY INC | Technology | $1.24B | 0.01% |
207AMPH | AMPHASTAR PHARMACEUTICALS INC | Healthcare | $1.23B | 0.01% |
208ADNT | ADIENT PLC | Consumer Cyclical | $1.22B | 0.01% |
209FRNM | FREENOME INC | Healthcare | $1.14B | 0.01% |
210GLIBA | LIBERTY CAPITAL CORP | Communication Services | $1.13B | 0.01% |
211TPB | TURNING POINT BRANDS INC | Consumer Defensive | $1.11B | 0.01% |
212ATEC | ALPHATEC HOLDINGS INC | Healthcare | $1.10B | 0.01% |
213IRMD | IRADIMED CORP | Healthcare | $1.09B | 0.01% |
214SBGI | SINCLAIR INC | Communication Services | $1.06B | 0.01% |
215XPEL | XPEL INC | Consumer Cyclical | $1.04B | 0.01% |
216SMP | STANDARD MOTOR PRODUCTS INC | Consumer Cyclical | $982M | 0.01% |
217NMAX | NEWSMAX INC | Communication Services | $942M | 0.01% |
218BVS | BIOVENTUS INC | Healthcare | $915M | 0.01% |
219WGO | WINNEBAGO INDUSTRIES INC | Consumer Cyclical | $883M | 0.01% |
220MAX | MEDIAALPHA INC | Communication Services | $877M | 0.01% |
221EVC | ENTRAVISION COMMUNICATIONS CORP | Communication Services | $870M | 0.01% |
222RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $860M | 0.01% |
223MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $844M | 0.01% |
224WEST | WESTROCK COFFEE CO | Consumer Defensive | $841M | 0.01% |
225COLL | COLLEGIUM PHARMACEUTICAL INC | Healthcare | $775M | 0.00% |
226CCSI | CONSENSUS CLOUD SOLUTIONS INC | Technology | $771M | 0.00% |
227PKOH | PARK OHIO HOLDINGS CORP | Industrials | $679M | 0.00% |
228ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | $664M | 0.00% |
229QMCO | QUANTUM CORP | Technology | $658M | 0.00% |
230CCXI | CHURCHILL CAPITAL CORP XI | Financial Services | $641M | 0.00% |
231SRZN | SURROZEN INC | Healthcare | $604M | 0.00% |
232GTN | GRAY MEDIA INC | Communication Services | $598M | 0.00% |
233CEPF | CANTOR EQUITY PARTNERS IV INC | Financial Services | $590M | 0.00% |
234FWRD | FORWARD AIR CORP | Industrials | $579M | 0.00% |
235SHEN | SHENANDOAH TELECOMMUNICATIONS CO | Communication Services | $568M | 0.00% |
236NRC | NRC HEALTH | Healthcare | $565M | 0.00% |
237MLR | MILLER INDUSTRIES INC | Consumer Cyclical | $551M | 0.00% |
238RCEL | AVITA MEDICAL INC | Healthcare | $509M | 0.00% |
239PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | $506M | 0.00% |
240EOLS | EVOLUS INC | Healthcare | $475M | 0.00% |
241CTEV | CLARITEV CORP | Healthcare | $459M | 0.00% |
242ATNI | ATN INTERNATIONAL INC | Communication Services | $448M | 0.00% |
243KRAQ | KRAKACQUISITION CORP | Financial Services | $433M | 0.00% |
244PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $418M | 0.00% |
245ASMB | ASSEMBLY BIOSCIENCES INC | Healthcare | $411M | 0.00% |
246AMCX | AMC GLOBAL MEDIA INC | Communication Services | $384M | 0.00% |
247GIW | GIGCAPITAL8 CORP | Financial Services | $372M | 0.00% |
248CEPV | CANTOR EQUITY PARTNERS V INC | Financial Services | $325M | 0.00% |
249CPS | COOPER-STANDARD HOLDINGS INC | Consumer Cyclical | $323M | 0.00% |
250OTGA | OTG ACQUISITION CORP I | Financial Services | $305M | 0.00% |
251ENHA | ENHANCED GROUP INC | Consumer Defensive | $279M | 0.00% |
252CEPO | CANTOR EQUITY PARTNERS I INC | Financial Services | $276M | 0.00% |
253QTTB | Q32 BIO INC | Healthcare | $264M | 0.00% |
254LE | LANDS' END INC | Consumer Cyclical | $264M | 0.00% |
255VNME | VENDOME ACQUISITION CORP I | Financial Services | $260M | 0.00% |
256STRT | STRATTEC SECURITY CORP | Consumer Cyclical | $251M | 0.00% |
257SPOK | SPOK HOLDINGS INC | Healthcare | $243M | 0.00% |
258LFCR | LIFECORE BIOMEDICAL INC | Healthcare | $243M | 0.00% |
259PDEX | PRO DEX INC | Healthcare | $216M | 0.00% |
260ELMD | ELECTROMED INC | Healthcare | $204M | 0.00% |
261AIIA | AI INFRASTRUCTURE ACQUISITION CORP | Financial Services | $199M | 0.00% |
262RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $194M | 0.00% |
263ALTG | ALTA EQUIPMENT GROUP INC | Industrials | $186M | 0.00% |
264NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $178M | 0.00% |
265NMP | NMP ACQUISITION CORP | Financial Services | $167M | 0.00% |
266EMIS | EMMIS ACQUISITION CORP | Financial Services | $163M | 0.00% |
267STRO | SUTRO BIOPHARMA INC | Healthcare | $159M | 0.00% |
268CEPS | CANTOR EQUITY PARTNERS VI INC | Financial Services | $149M | 0.00% |
269TRAD | APEX TECH ACQUISITION INC | Financial Services | $148M | 0.00% |
270MPAA | MOTORCAR PARTS OF AMERICA INC | Consumer Cyclical | $146M | 0.00% |
271RFAM | RF ACQUISITION CORP III | Financial Services | $140M | 0.00% |
272ALDFF | ALDEL FINANCIAL II INC | Financial Services | $109M | 0.00% |
273TISI | TEAM INC | Industrials | $107M | 0.00% |
274BYND | BEYOND MEAT INC | Consumer Defensive | $102M | 0.00% |
275ICCC | IMMUCELL CORP | Healthcare | $93M | 0.00% |
276ORIQ | ORIGIN INVESTMENT CORP I | Financial Services | $90M | 0.00% |
277RLYB | RALLYBIO CORP | Healthcare | $84M | 0.00% |
278APAC | STONEBRIDGE ACQUISITION II CORP | Financial Services | $83M | 0.00% |
279AIRT | AIR T INC | Industrials | $81M | 0.00% |
280ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $81M | 0.00% |
281FTLF | FITLIFE BRANDS INC | Consumer Defensive | $78M | 0.00% |
282RANG | RANGE CAPITAL ACQUISITION CORP | Financial Services | $73M | 0.00% |
283ALIS | CALISA ACQUISITION CORP | Financial Services | $71M | 0.00% |
284GOSS | GOSSAMER BIO INC | Healthcare | $69M | 0.00% |
285LFVN | LIFEVANTAGE CORP | Consumer Defensive | $64M | 0.00% |
286UYSC | UY SCUTI ACQUISITION CORP | Financial Services | $58M | 0.00% |
287COCH | ENVOY MEDICAL INC | Healthcare | $53M | 0.00% |
Full long-leg book as of November 2026 · cap-weighted · total market cap $15.96T. Hypothetical model holdings — not a registered fund’s portfolio.
Size × value map of the long-leg book
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
No more than 25% of total assets may be invested in the securities of any one issuer.
Close to the line. The engine flags this verdict as one a routine data rebuild could flip. Read it as borderline rather than settled — the margin beside it is the whole story.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Days required to liquidate the largest position at 20% of one day's dollar volume.
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
1 verdict(s) sit within 1.0pp of their limit and can be flipped by a routine data rebuild; do not headline them, and always show the margin.
Data version — panel=20261113T032607 rows=2198308 asof=202611 issuers=20261113T063725 rates=20261113T063725
Measured on the 2026-11 formation date across 287 holdings (cap-weighted). A different formation date can produce different verdicts.
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 335 monthly observations · about 3.4 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 21%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Did the edge survive the paper coming out?
There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 16.2% | -0.6% |
| 3 yearsp.a. | 18.0% | -2.9% |
| 5 yearsp.a. | 16.9% | 8.0% |
| 10 yearsp.a. | 16.6% | 4.6% |
| Since inceptionp.a. | 8.7% | 0.3% |
| Year | Long leg | Long-short |
|---|---|---|
| 202611 mo | 15.0% | -3.8% |
| 2025 | 7.8% | -14.5% |
| 2024 | 29.0% | 12.9% |
| 2023 | 40.8% | 19.5% |
| 2022 | -7.9% | 28.6% |
| 2021 | 29.9% | 20.1% |
| 2020 | 17.2% | -11.9% |
| 2019 | 30.5% | 5.1% |
| 2018 | -7.1% | -3.8% |
| 2017 | 20.1% | 2.9% |
| 2016 | 11.3% | -13.1% |
| 2015 | 6.7% | 13.9% |
| 2014 | 18.0% | 28.1% |
| 2013 | 38.3% | 7.1% |
| 2012 | 23.6% | 5.4% |
| 2011 | 6.9% | 3.0% |
| 2010 | 12.1% | -8.1% |
| 2009 | 20.9% | -16.0% |
| 2008 | -30.7% | 11.2% |
| 2007 | 11.6% | 7.9% |
| 2006 | 10.3% | -7.3% |
| 2005 | 1.4% | -9.8% |
| 2004 | 11.1% | -1.4% |
| 2003 | 28.2% | -3.4% |
| 2002 | -30.3% | -2.6% |
| 2001 | -13.8% | -7.4% |
| 2000 | -32.2% | -35.0% |
| 1999 | 28.5% | 7.8% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through November 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
The Foundry Return on Equity Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Return on Equity signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,140-name universe at November 2026. Rows: Large ≥ $5.3B, Small < $832M. Columns: Value ≥ 0.62, Growth < 0.33 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 83% toward Growth. +1% unclassified (38 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → November 2026; the right-hand end is the same value as the box’s dot. 287 names now. Hypothetical holdings — descriptive, not P&L.